CGM is a report plus a clinic note
Time-in-range, hypoglycemia, and sensor wear have to be interpreted (95251) and then translated into an insulin change. One paragraph cannot do both.
Endocrinology
Diabetes technology, thyroid, and obesity meds — CGM interpretation, titration notes, and device prior-auths drafted from the visit.
The problem
Time-in-range, hypoglycemia, and sensor wear have to be interpreted (95251) and then translated into an insulin change. One paragraph cannot do both.
GI side effects, dose steps, contraindications, and weight trajectory need a dedicated follow-up structure — not a recycled diabetes SOAP.
Payers want A1c, hypoglycemia, SMBG frequency, and failed alternatives. Assembling that after clinic delays devices by weeks.
How Augustun fits
Diabetes, thyroid, bone, and pituitary visits capture labs, doses, and technology settings from the conversation.
Ambulatory glucose profile findings are structured into an interpretation report, then linked to the titration plan.
Diabetes and thyroid ICD-10 plus CGM professional interpretation CPT are proposed from documented review.
CGM initiation and interpretation, anti-obesity titration notes, and diabetes-technology prior-auth letters.
Outcomes
2+
Hours saved per endocrinologist per day on CGM and titration notes
95251
CGM interpretation structured as a billable report
400+
EHRs via browser extension (Epic, athena, Cerner)
FAQ
Yes. Time-in-range, hypoglycemia, and pattern comments discussed in the visit are structured into a CGM interpretation report.
Yes. Dose, side effects, contraindications, and weight change are captured in a dedicated titration note.
Yes. Clinical criteria discussed in clinic are drafted into a diabetes-technology prior-auth request you review.
Free templates
Ready-to-use SOAP, BIRP, and specialty note templates you can copy into your workflow today.
Start free — no credit card required. Most clinicians are live in under 10 minutes.
Ask AI about Augustun: